Controlled Study of Guanfacine XR in ADHD
Abstract
A multicenter, double-blind, placebo-controlled, fixed-dosage escalation study of an extended release formulation of guanfacine is reported from the Massachusetts General Hospital, Boston, and other centers in the US and UK.
DOI: https://doi.org/10.15844/pedneurbriefs-22-1-9 | Journal eISSN: 2166-6482
Language: English
Page range: 8 - 8
Published on: Jan 1, 2008
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2008 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.